Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 943823, 11 pages
Review Article

Challenges in Treating Older Patients with Acute Myeloid Leukemia

Division of Hematology/BMT Unit, Patras University Hospital, Patras, Greece

Received 31 December 2009; Accepted 27 March 2010

Academic Editor: Thomas R. Chauncey

Copyright © 2010 Lagadinou D. Eleni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [12 citations]

The following is the list of published articles that have cited the current article.

  • Lieke H. van der Helm, Ellen R. M. Scheepers, Nic J. G. M. Veeger, Simon M. G. J. Daenen, Andre B. Mulder, Eva van den Berg, Edo Vellenga, and Gerwin Huls, “Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients,” Journal Of Hematology & Oncology, vol. 6, 2013. View at Publisher · View at Google Scholar
  • Michael Cross, T Thao Tran, Rainer Krahl, Georg Maschmeyer, Dietger Niederwieser, Christian Junghanss, Enrica Bach, Nadja Jaekel, and Haifa Kathrin Al-Ali, “Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemia,” Oncotargets And Therapy, vol. 6, pp. 741–748, 2013. View at Publisher · View at Google Scholar
  • Imit Kaur, Jonathan E Constance, Ken M Kosak, Michael G Spigarelli, and Catherine MT Sherwin, “An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia,” Expert Opinion on Drug Metabolism & Toxicology, pp. 1–13, 2014. View at Publisher · View at Google Scholar
  • Mario Delia, Paola Carluccio, Caterina Buquicchio, Carolina Vergine, Giuseppina Greco, Barbara Amurri, Angela Melpignano, Lorella Melillo, Nicola Cascavilla, Attilio Guarini, Silvana Capalbo, Giuseppe Tarantini, Patrizio Mazza, Vincenzo Pavone, Nicola Di Renzo, and Giorgina Specchia, “Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP),” Leukemia Research, 2015. View at Publisher · View at Google Scholar
  • Hawk Kim, Je-Hwan Lee, Young-Don Joo, Sung Hwa Bae, Jung-Hee Lee, Dae-Young Kim, Won-Sik Lee, Hun-Mo Ryoo, Jae-Cheol Jo, Yunsuk Choi, and Kyoo-Hyung Lee, “A prospective, multicenter phase II study of continuous infusion of FLAG for patients older than 60 yr with resistant acute myeloid leukemia: a comparison with intensive younger patients’ trial,” European Journal of Haematology, 2015. View at Publisher · View at Google Scholar
  • Naomi Sugimori, J. Luis Espinoza, Ly Quoc Trung, Akiyoshi Takami, Yukio Kondo, Dao Thi An, Motoko Sasaki, Tomohiko Wakayama, and Shinji Nakao, “Paraptosis Cell Death Induction by the Thiamine Analog Benfotiamine in Leukemia Cells,” Plos One, vol. 10, no. 4, 2015. View at Publisher · View at Google Scholar
  • Rosalia de Necochea-Campion, Geoffrey P. Shouse, Qi Zhou, Saied Mirshahidi, and Chien-Shing Chen, “Aberrant splicing and drug resistance in AML,” Journal of Hematology & Oncology, vol. 9, no. 1, 2016. View at Publisher · View at Google Scholar
  • Sorina Suarasan, Timea Simon, Sanda Boca, Ciprian Tomuleasa, and Simion Astilean, “Gelatin-coated Gold Nanoparticles as Carriers of FLT3 Inhibitors for Acute Myeloid Leukemia Treatment,” Chemical Biology & Drug Design, vol. 87, no. 6, pp. 927–935, 2016. View at Publisher · View at Google Scholar
  • Pablo Loarte, Leanne Tortez, Andrzej Kozikowski, Ramy Ibrahim, Renee Pekmezaris, Irina Dashkova, and Anna Dashkova, “Understanding unmet needs in the older acute myeloid leukemia (AML) patient,” Current Cancer Therapy Reviews, vol. 12, no. 4, pp. 246–252, 2016. View at Publisher · View at Google Scholar
  • Maria Elena Martinez, Mark Ghamsary, Matthew J. Wieduwilt, Brice Jabo, and John W. Morgan, “Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients,” PLoS ONE, vol. 12, no. 4, 2017. View at Publisher · View at Google Scholar
  • Heron F. Vieira Torquato, Antonio C. Ribeiro-Filho, Marcus V. Buri, Roberto T. Araújo Júnior, Renata Pimenta, José Salvador R. de Oliveira, Valdir C. Filho, Antonio Macho, Edgar J. Paredes-Gamero, and Domingos T. de Oliveira Martins, “Canthin-6-one induces cell death, cell cycle arrest and differentiation in human myeloid leukemia cells,” Biochimica et Biophysica Acta (BBA) - General Subjects, 2017. View at Publisher · View at Google Scholar
  • Gianni B. Scappaticci, Bernard L. Marini, Victoria R. Nachar, James R. Uebel, Vera Vulaj, Ashley Crouch, Dale L. Bixby, Moshe Talpaz, and Anthony J. Perissinotti, “Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG,” Annals of Hematology, 2017. View at Publisher · View at Google Scholar